Company insiders — CEOs, CFOs, directors and 10% owners — buying their own company's stock on the open market: every purchase of $250K or more from the previous day's Form 4 filings, largest first, with an AI summary of the day.
Bought 61,068 shares at $6.73 avg via Harari Family Trust on July 17; now $7.02 (+4.3% since buy). Post-transaction stake ~3.34M shares. Co-founder adding to large existing position. CapsoVision IPO'd Nasdaq July 2025 at $5.00.
AIThe day in insider buying
SEC Form 4 Insider Scan — July 22, 2026
Scanned the last 24 hours of EDGAR Form 4 filings. 1 qualifying buy (≥ $250K, transaction type P) totalling $411K.
Headline filings
CV — Eliyahou Harari (10% Owner) bought 61,068 shares ≈ $411K at $6.73 avg; now $7.02 (+4.3% since buy). (filing)
Notes
Light day for conviction buying. The only qualifying open-market purchase came from CapsoVision Inc. (NASDAQ: CV), a commercial-stage medical technology company focused on capsule endoscopy solutions with an AI-enhanced diagnostic platform. Eliyahou Harari — co-founder and 10%+ owner — added 61,068 shares via the Harari Family Trust at $6.73 on July 17 (filed July 21). The transaction adds to an already substantial stake of ~3.3 million shares. CapsoVision IPO'd on Nasdaq in July 2025 at $5.00; Harari's buy at $6.73 is now modestly in the green at $7.02 (+4.3% since purchase).
The bulk of July 21 Form 4 filings consisted of routine 10b5-1 plan sales (Sea Ltd COO/CCO, CrowdStrike CEO, Phillips 66 EVP, MeiraGTx CFO, AppFolio 10% owner, ZipRecruiter CPO), RSU vesting and mandatory tax-withholding events (AngioDynamics board cluster, Western Digital CLO, BioLife Solutions, Enovix CEO, TWFG executives), and equity compensation grants (Roivant Sciences directors, CrossAmerica Partners directors). A $12.4M purchase by Fairmount Healthcare Fund II LP in Crescent Biopharma (CBIO) was flagged but excluded — it was participation in CBIO's registered public offering, not a discretionary open-market buy. No cluster purchases by operating executives or $1M+ CEO open-market buys were observed in this filing window.
Most-bought stocks, last 30 days
AVO$68.8M · 12 buys, 3 insidersMission Produce, Inc.
Source: insiders' SEC Form 4 filings — open-market purchases (transaction code P) of $250K or more filed in the previous day. Insiders must file within two business days of a trade, so a purchase can be a day or two older than its filing. Average price = value ÷ shares. Insiders buy for many reasons and a purchase is no guarantee the shares will rise. The summaries are written by AI as a research aid — not financial advice or a recommendation to buy or sell any security, and they can be wrong.
SPX Lens Insider Buying reads the SEC Form 4 filings insiders file after trading their own company's
stock and lists every open-market purchase of $250K or more — who bought, their role, how much and at what
average price. Insiders sell for many reasons, but they usually buy for one: they think the shares are worth more. It is free,
and a new scan is posted every trading day. How to read insider buying →
See where SPX is heading next. The SPX Lens chart shows key levels, live signals and an AI forecast for the next bars — free to try.